JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB14106

Anti-TAGLN/Transgelin 抗体

Anti-TAGLN/Transgelin antibody

5

(27 Reviews)

|

(536 Publications)

Anti-TAGLN/Transgelin antibody (ab14106) is a rabbit polyclonal antibody detecting TAGLN/Transgelin in Western Blot, ICC/IF. Suitable for Human, Mouse, Rat.

- Over 430 publications
- Trusted since 2005

別名を表示する

Sm22, Sm22a, Transgelin, Actin-associated protein p27, Smooth muscle protein 22-alpha, SM22-alpha

7 Images
Immunocytochemistry/ Immunofluorescence - Anti-TAGLN/Transgelin antibody (AB14106)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-TAGLN/Transgelin antibody (AB14106)

ab14106 stained HeLa (Human epithelial cell line from cervix adenocarcinoma) cells.

The cells were fixed in 100% methanol for 5 minutes, permeabilized in 0.1% PBS-Triton X-100 for 5 minutes and then incubated in 1% BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1 hour at room temperature to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab14106 at 1 μg/ml) overnight at +4°C. The secondary antibody (pseudo-colored green) was ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed used at a 1/1000 dilution for 1 hour at room temperature. Alexa Fluor® 594 WGA was used to label plasma membranes (pseudo-colored red) at a 1/200 dilution for 1 hour at room temperature.

DAPI was used to stain the cell nuclei (pseudo-colored blue) at a concentration of 1.43μM for 1 hour at room temperature.

Immunocytochemistry/ Immunofluorescence - Anti-TAGLN/Transgelin antibody (AB14106)
  • ICC/IF

AbReview42536****

Immunocytochemistry/ Immunofluorescence - Anti-TAGLN/Transgelin antibody (AB14106)

ab14106 staining SM22 alpha in mouse muscle cells by ICC/IF (Immunocytochemistry/immunofluorescence).

Cells were fixed with paraformaldehyde, permeabilized with 0.1% Triton X-100 and blocked with 10% serum for 30 minutes at 25°C. Samples were incubated with primary antibody (1/100 in PBS) for 18 hours at 4°C. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG polyclonal was used as the secondary antibody at a dilution of 1/1000.

This image is courtesy of an anonymous Abreview.

Western blot - Anti-TAGLN/Transgelin antibody (AB14106)
  • WB

Ap

Western blot - Anti-TAGLN/Transgelin antibody (AB14106)

This blot was produced using a 4-12% Bis-tris gel under the MES buffer system. The gel was run at 200V for 35 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab14106 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution ab133406.

All lanes:

Western blot - Anti-TAGLN/Transgelin antibody (ab14106) at 1 µg/mL

Lane 1:

Human colon tissue lysate - total protein (ab30051) at 10 µg

Lane 2:

Mouse colon tissue lysate at 10 µg

Lane 3:

Rat colon tissue lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG H&L (HRP) preadsorbed at 1/50000 dilution

Predicted band size: 23 kDa

Observed band size: 115 kDa,20 kDa,23 kDa,36 kDa

true

Exposure time: 5s

Western blot - Anti-TAGLN/Transgelin antibody (AB14106)
  • WB

Unknown

Western blot - Anti-TAGLN/Transgelin antibody (AB14106)

The band was completed abolished by peptide blocking with ab16067 (immunizing peptide) - not shown.

All lanes:

Western blot - Anti-TAGLN/Transgelin antibody (ab14106) at 1 µg/mL

Lane 1:

HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg

Lane 2:

HeLa nuclear extract at 20 µg

Lane 3:

Human skeletal muscle tissue lysate at 20 µg

Secondary

All lanes:

Alexa Fluor Goat polyclonal to Rabbit IgG at 1/10000 dilution

Predicted band size: 23 kDa

Observed band size: 23 kDa

false

Western blot - Anti-TAGLN/Transgelin antibody (AB14106)
  • WB

Unknown

Western blot - Anti-TAGLN/Transgelin antibody (AB14106)

All lanes:

Western blot - Anti-TAGLN/Transgelin antibody (ab14106) at 1 µg/mL

Lane 1:

Western blot - Recombinant Human TAGLN/Transgelin protein (His tag N-Terminus) (<a href='/products/proteins-peptides/recombinant-human-tagln-transgelin-protein-ab101469'>ab101469</a>) at 0.01 µg

Lane 1:

Western blot - Recombinant Human SPG21/Maspardin protein (His tag N-Terminus) (<a href='/products/proteins-peptides/recombinant-human-spg21-maspardin-protein-ab86438'>ab86438</a>)

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution

Predicted band size: 23 kDa,35 kDa

true

Exposure time: 30s

Western blot - Anti-TAGLN/Transgelin antibody (AB14106)
  • WB

AbReview16283****

Western blot - Anti-TAGLN/Transgelin antibody (AB14106)

All lanes:

Western blot - Anti-TAGLN/Transgelin antibody (ab14106) at 1/1000 dilution

All lanes:

Lysates prepared from human primary smooth muscle cells at 30 µg

Secondary

All lanes:

HRP-conjugated bovine polyclonal to rabbit IgG at 1/2000 dilution

Predicted band size: 23 kDa

Observed band size: 23 kDa

true

Exposure time: 2min

This image is a courtesy of Anonymous Abreview

Western blot - Anti-TAGLN/Transgelin antibody (AB14106)
  • WB

CiteAb

Western blot - Anti-TAGLN/Transgelin antibody (AB14106)

Western Blotting using Anti-TAGLN/Transgelin antibody, ab14106. Publication image from Boehm, M. et al., 2016, Nat Commun, 27340017. Legend direct from paper.

Hypoxia increases EndMT and is additive to the effect of TGF-β.(a) Representative pimonidazole staining demonstrating the extent of hypoxia in aortic sections from tamoxifen-induced end.SclCreERT;R26RstopYfp;ApoE−/− mice fed 8 versus 18 weeks HFD. Staining in red is indicative of hypoxia with pO2 <10 mm Hg. Specific staining was performed using pimonidazole (seen in red) and DAPI (blue). L=lumen; scale bars, 100 µm. Staining was performed on at least three spatially separated thoracic aortic sections per mouse (n=5 mice per group). Analysis by one-way ANOVA; overall P<0.0001. (b) Immunostaining of HCAECs exposed to hypoxia and/or TGF-β for 5 days in vitro. Scale bars, 100 µm. (c–f) Relative RNA expression of mesenchymal genes FAP, SM22α, Calponin and Versican (respectively) in HCAECs was increased by hypoxia as assessed by qRT-PCR. (g–j) Relative RNA expression of endothelial genes CD31, Ve-Cadherin, eNOS and KDR assessed by qRT-PCR showed mixed effects in response to hypoxia. (k–l) Relative RNA expression of SNAI2 and SNAI1 in HCAECs was increased by hypoxia. (m) SM22α protein expression, assessed by western blot in HCAECs, was increased by hypoxia as indicated. SM22α ladder (L) represents 25 kDa (upper), 20 kDa (middle) and 15 kDa (lower). SM22α expected molecular weight/size is 23 kDa. GAPDH ladder represents 37 kDa. GAPDH expected molecular weight/size is 37 kDa. (n) CD31 protein expression, assessed by western blot in HCAECs. CD31 ladder (L) represents 150 kDa. CD31 expected molecular weight/size is 130 kDa. GAPDH ladder represents 37 kDa. GAPDH expected molecular weight/size is 37 kDa. As our intent was to evaluate the specific effect of hypoxia, and not interactions with TGF-β (which is provided as a reference), t testing was performed in this case. n=3 in all experiments. All experiments replicated >3 times. NS, not significant, *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.

false

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Mouse, Rat, Human

アプリケーション

ICC/IF, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特異性

The immunogen used to generate this TAGLN/Transgelin antibody (ab14106) shares 75% homology with family members TAGLN2 and TAGLN3. Cross-reactivity with these proteins has not been confirmed experimentally.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

製品の詳細

Product Specifications
Anti-TAGLN/Transgelin antibody (ab14106) is a rabbit polyclonal antibody and is validated for use in ICC/IF, WB in human, mouse, rat samples.

Quality and Validation
Anti-TAGLN/Transgelin antibody (ab14106) specifically detects TAGLN/Transgelin (UniProt ID: Q01995; Molecular weight: 22kDa) and is sold in 100 µg selling sizes.
Abcam's high quality validation processes ensure Anti-TAGLN/Transgelin antibody (ab14106) has high sensitivity and specificity.
Anti-TAGLN/Transgelin antibody (ab14106) has been cited over 435 times in peer reviewed journals and is trusted by the scientific community.
Anti-TAGLN/Transgelin antibody (ab14106) has 27 independent reviews from customers.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

TAGLN also known as Transgelin or SM22-alpha is a protein with a molecular weight of approximately 22 kDa. Structurally it belongs to the calponin family and contains an ACT domain which is critical for its actin-binding ability. It is expressed abundantly in smooth muscle cells where it stabilizes cytoskeletal dynamics by interacting with actin filaments. TAGLN also shows expression in fibroblasts and myofibroblasts supporting structural integrity and cellular movement.
Biological function summary

The regulatory involvement of TAGLN in smooth muscle contraction influences cellular activities essential for vascular function. This protein modulates remodeling and differentiation within smooth muscle cells. It can associate with actin and calponin to form complexes that regulate the stability of cytoskeletal structures ensuring effective cellular responses to mechanical stimuli. By linking signal transduction to cytoskeletal mechanics TAGLN facilitates the maintenance of cell shape and tension.

Pathways

TAGLN plays a role in the regulation of the RhoA/Rho kinase pathway contributing to actin cytoskeleton organization and smooth muscle contraction. Additionally it is involved in the WNT signaling pathway influencing cell proliferation and differentiation. In these pathways TAGLN works with proteins like RhoA and beta-catenin to transmit signals from the extracellular environment to the nucleus impacting gene expression and cellular responses.

Disruptions in TAGLN expression associate with vascular diseases and certain cancers. Downregulation or altered expression patterns can lead to smooth muscle cell dysfunction contributing to atherosclerosis. Similarly TAGLN interacts with proteins such as fibronectin and MMP2 in cancer where its altered expression could promote metastasis and tumor progression. Understanding these connections highlights TAGLN's potential as a target for therapeutic interventions in these diseases.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Actin cross-linking/gelling protein.
See full target information Tagln

文献 (536)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 16:678 PubMed41053113

2025

SDC4 drives fibrotic remodeling of the intervertebral disc under altered spinal loading.

Applications

Unspecified application

Species

Unspecified reactive species

Kimheak Sao,Makarand V Risbud

Bioactive materials 55:257-270 PubMed41050141

2025

Synergistic fusion of CD47, VE-cadherin and mussel adhesion protein promotes endothelialization and suppresses inflammation in vascular stents.

Applications

Unspecified application

Species

Unspecified reactive species

Wenhua Yan,Shuyu Li,Tian Zhang,Junli Huang,Chengchen Deng,Kunshan Yuan,Nan Huang,Haijun Zhang,Guixue Wang

Journal of cell communication and signaling 19:e70048 PubMed41040887

2025

Targeting the PI3K/Akt/NF-κB axis: Cluster of differentiation 5-like-mediated immunometabolic regulation of macrophage polarization in abdominal aortic aneurysm.

Applications

Unspecified application

Species

Unspecified reactive species

Hemoren Yi,Nan Liu,Zhengyang Wu,Lei Li,Tingting Li,Qixiang Liu,Man Duan,Taihu Wan

Journal of biomedical science 32:78 PubMed40836335

2025

Smooth muscle-specific expression of hydroxyindole O-methyltransferase reduces arterial injury-induced intimal hyperplasia.

Applications

Unspecified application

Species

Unspecified reactive species

Wei-Cheng Jiang,Chung-Huang Chen,Hua-Hui Ho,Pei-Yu Gung,Jing-Yiing Wu,Cheng-Chin Kuo,Kenneth K Wu,Shaw-Fang Yet

Nature neuroscience 28:1868-1882 PubMed40796665

2025

Impaired capillary-venous drainage contributes to gliosis and demyelination in mouse white matter during aging.

Applications

Unspecified application

Species

Unspecified reactive species

Stefan Stamenkovic,Franca Schmid,Gokce Gurler,Farzaneh Abolmaali,Nicolas A Weitermann,Kevin T Takasaki,Stephanie K Bonney,Maria J Sosa,Hannah C Bennett,Yongsoo Kim,Jack Waters,Andy Y Shih

Scientific reports 15:24657 PubMed40634394

2025

Knockdown of RGMa reduces vascular calcification by inhibiting the AKT signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Hongmei Xiao,Guanru Shen,Zijie Wang,Xiaofan Yuan,Yue Ma,Ruiqi Cheng,Xinyue Qin

Nature communications 16:6232 PubMed40623996

2025

Orphan receptor GPR153 facilitates vascular damage responses by modulating cAMP levels, YAP/TAZ signaling, and NF-κB activation.

Applications

Unspecified application

Species

Unspecified reactive species

Jingchen Shao,Jeonghyeon Kwon,Tianpeng Wang,Stefan Günther,Lukas S Tombor,Timothy Warwick,Zaib Shaheryar,Ralf P Brandes,Stefanie Dimmeler,Jan Wenzel,Stefan Offermanns,Markus Schwaninger,Nina Wettschureck

Nature communications 16:6241 PubMed40624080

2025

Vesicle-associated membrane protein 5 is an intrinsic defense factor for embryonic stem cells against coronaviruses.

Applications

Unspecified application

Species

Unspecified reactive species

Huijun Dong,Zihang Pan,Pengtao Jiao,Fei Ye,Qi Peng,Yanying Yu,Xinyuan Lai,Huan Li,Zhao Guan,Juan Deng,Tao Shen,Wenjie Tan,Yi Shi,Qiang Ding,Jianyuan Luo,Tong Li,Hui Zhuang,Kuanhui Xiang

eLife 13: PubMed40622747

2025

The ESCRT protein CHMP5 restricts bone formation by controlling endolysosome-mitochondrion-mediated cell senescence.

Applications

Unspecified application

Species

Unspecified reactive species

Fan Zhang,Yuan Wang,Luyang Zhang,Chunjie Wang,Deping Chen,Haibo Liu,Ren Xu,Cole M Haynes,Jae-Hyuck Shim,Xianpeng Ge

Bio-protocol 15:e5355 PubMed40620805

2025

Primary Mouse Choroidal Endothelial Cell Culture.

Applications

Unspecified application

Species

Unspecified reactive species

Qiuhua Yang,Yongfeng Cai,Qian Ma,Yuqing Huo
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com